Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8442620 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Antifungal Use in Oncohematological Neutropenic Patients
Condition: Invader Fungal Infection
Intervention: Drug: Antifungal drug. VORICONAZOL. (VFEND®)

Indicates status has not been verified in more than two years